Israel’s Inspira Technologies (see here previously) announced positive results from the clinical study at Sheba Hospital of its AI-powered HYLA blood sensor. Its real-time blood monitoring enables early diagnosis and personalized care without the need for intermittent blood draws.

https://www.prnewswire.com/news-releases/inspira-technologies-announces-positive-results-from-clinical-study-of-hyla-blood-sensor-achieving-96-accuracy-302391551.html